Andrew J. Lewis
Parks Road
Oxford, ENG, United Kingdom
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes.
Journal: Circulation
Published: December 18, 2025
Immunomodulation by AZD1656 reverses cardiac dysfunction, metabolic remodelling and reduces infarct size in type 2 diabetic cardiomyopathy.
Journal: bioRxiv : the preprint server for biology
Published: April 28, 2025
A Mitochondrial Basis for Heart Failure Progression.
Journal: Cardiovascular drugs and therapy
Published: May 20, 2024
Functional and Metabolic Imaging in Heart Failure with Preserved Ejection Fraction: Promises, Challenges, and Clinical Utility.
Journal: Cardiovascular drugs and therapy
Published: June 08, 2022
Hyperpolarized [1,4-13C2]Fumarate Enables Magnetic Resonance-Based Imaging of Myocardial Necrosis.
Journal: JACC. Cardiovascular imaging
Published: January 15, 2017
Pyruvate dehydrogenase as a therapeutic target for obesity cardiomyopathy.
Journal: Expert opinion on therapeutic targets
Published: December 01, 2015
Increasing Pyruvate Dehydrogenase Flux as a Treatment for Diabetic Cardiomyopathy: A Combined 13C Hyperpolarized Magnetic Resonance and Echocardiography Study.
Journal: Diabetes
Published: October 20, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026